MBMaximilian Berger

Maximilian Berger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maximilian Berger has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Pichit Buspavanich

    Charité Center for Prevention, Health and Human Sciences, Research Unit Gender in Medicine, Charité—University Medical Center Berlin, 13353 Berlin, Germany

    3 shared publications
  • Eva Lermer

    Technical University of Applied Sciences Augsburg

    2 shared publications
  • Joachim Behr

    Department of Psychiatry, Psychotherapy and Psychosomatics Brandenburg Medical School Theodor Fontane Neuruppin Germany

    2 shared publications
  • Sonia Lech

    Department of Psychiatry and Neurosciences, and Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany

    2 shared publications
  • Christian J. Thaler

    Affiliation Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich, Munich, Germany

    1 shared publication
  • Cj Thaler

    University Hospital, LMU Munich, Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, Munich, Deutschland

    1 shared publication

Latest Publications

  • Open Access

    Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms

    by Hannah Buchbauer, Mazda Adli, Peter Schlattmann, Maximilian Berger, Tom Bschor, Thomas Stamm, Joachim Behr, Roland Ricken, Pichit Buspavanich

    Introduction: Understanding the differences in treatment response between subtypes of major depressive disorder (MDD) may help to prevent lengthy trial‐and‐error processes by identifying effective treatment options. The aim of the study was to investigate the impact of atypical features of MDD (MDD‐A) on the response to lithium augmentation (LA). Methods: In a multicenter prospective cohort study, response to LA was compared between patients with atypical symptoms of MDD (MDD‐A, n = 24) versus patients without atypical symptoms (MDD‐nA; n = 94) using a Cox regression analysis. Results: A total of 62.5% of patients with MDD‐A and 36.2% of patients with MDD‐nA responded to LA. Analysis adjusted for age, sex, sufficient lithium serum concentration, and symptom severity at baseline showed a significantly higher probability of patients with atypical symptoms to respond to LA (HR 2.20, p = 0.02). Conclusion: This is the first study investigating lithium‐response in patients with MDD‐A. The MDD‐A subtype may help to predict response to LA. Trial Registration: EudraCT number: 2008‐004182‐26; ClinicalTrials.gov identifier: DRKS00026205


  • „Eltern werden“ – Wie die COVID-19 Pandemie den Kinderwunsch von sexuellen Minoritäten beeinflusst

    by F Batz, E Lermer, S Lech, M Franz, M Berger, S Mahner, Cj Thaler, P Buspavanich

    Hintergrund Lesben, Schwule und Bisexuelle (LGB*)Personen haben zunehmend mehr Möglichkeiten, einen Kinderwunsch zu realisieren. Kinderwunschmotive und individuelle Lebensentwürfe werden inneren und äußeren Einflussfaktoren bestimmt. Dabei müssen LGB* Personen besondere Hindernisse überwinden, um ihren Kinderwunsch zu verwirklichen. Es gibt erste Hinweise, dass LGB*Personen stärker von depressiven Symptomen in der COVID-19-Pandemie betroffen sind, als cis-Heterosexuelle. Offen ist jedoch, inwiefern Depressivität den Kinderwunsch bei LGB*Personen und cis-Heterosexuellen beeinflusst. Methode Es wurden Daten einer deutschlandweiten Onlinebefragung von April 2020 bis Juli 2020 (N=2135) verwendet. Demografischen Daten, psychisches Wohlbefinden (PHQ-4-Score) und Kinderwunschmotive (LKM-20) von LGB* Personen (n = 832) und cis-Heterosexuellen (n=1304) wurde abgefragt. Ergebnisse LGB*Personen zeigten verglichen mit cis-Heterosexuellen ein signifikant häufiger depressive Symptome (PHQ-4 Summenscore: n=211 (29,6%) vs. n=227 (20.1%); p=0,019). Die Ausprägungen der Kinderwunschmotive zeigten auf allen Skalen („Emotionale Stabilisierung und Sinnfindung“ oder „Soziale Anerkennung und Identitätsbildung“) signifikant niedrigere Werte bei LGB*Personen verglichen mit cis-Heterosexuellen (LKM-20 Summenscore: M=2,35 vs. M=2,96; p=0,008). Allerdings fand sich in keiner der beiden Gruppen eine Veränderung seit Beginn der COVID-19-Pandemie. Daneben zeigte sich eine signifikant negative Assoziation zwischen dem Kinderwunsch und depressiven Symptomen (p=0,032). Diskussion Durch strukturelle Marginalisierung und individuelle Diskriminierungserfahrungen weisen LGB*Personen ein erhöhtes Risiko für psychische Belastungen auf. Der Wunsch und die Möglichkeiten, eigene Kinder zu bekommen scheint dabei mit dem psychischen Wohlbefinden eng verknüpft zu sein. In diesem Kontext sollen in weiterführenden Studien relevante Risiko- und Schutzfaktoren und deren zugrundeliegenden Mechanismen identifiziert werden. Das Ziel sollte sein eine Strategie zur Förderung von Kinderwunsch von LGB*Personen abzuleiten. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Well-being during COVID-19 pandemic: A comparison of individuals with minoritized sexual and gender identities and cis-heterosexual individuals

    by Pichit Buspavanich, Sonia Lech, Eva Lermer, Mirjam Fischer, Maximilian Berger, Theresa Vilsmaier, Till Kaltofen, Simon Keckstein, Sven Mahner, Joachim Behr, et al.

    Background: Preliminary empirical data indicates a substantial impact of the COVID-19 pandemic on well-being and mental health. Individuals with minoritized sexual and gender identities are at a higher risk of experiencing such negative changes in their well-being. The objective of this study was to compare levels of well-being among cis-heterosexual individuals and individuals with minoritized sexual and gender identities during the COVID-19 pandemic. Methods: Using data obtained in a cross-sectional online survey between April 20 to July 20, 2020 (N = 2332), we compared levels of well-being (WHO-5) across subgroups (cis-individuals with minoritized sexual identities, individuals with minoritized gender identities and cis-heterosexual individuals) applying univariate (two-sample t-test) and multivariate analysis (multivariate linear regression). Results: Results indicate overall lower levels of well-being as well as lower levels of well-being in minoritized sexual or gender identities compared to cis-heterosexual individuals. Further, multivariate analyses revealed that living in urban communities as well as being in a relationship were positively associated with higher levels of well-being. Furthermore, a moderation analysis showed that being in a relationship reduces the difference between groups in terms of well-being. Conclusion: Access to mental healthcare for individuals with minoritized sexual and gender identities as well as access to gender-affirming resources should be strengthened during COVID-19 pandemic. Healthcare services with low barriers of access such as telehealth and online peer support groups should be made available, especially for vulnerable groups.